Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/2067/45991
Titolo: | New therapeutic strategy for overcoming multidrug resistance in cancer cells with pyrazolo[3,4‐d]pyrimidine tyrosine kinase inhibitors | Autori: | Podolski‐renić, Ana Dinić, Jelena Stanković, Tijana Tsakovska, Ivanka Pajeva, Ilza Tuccinardi, Tiziano botta, lorenzo Schenone, Silvia Pešić, Milica |
Rivista: | CANCERS | Data pubblicazione: | 2021 | Abstract: | Tyrosine kinase inhibitors (TKIs) often interact with the multidrug resistant (MDR) phenotype of cancer cells. In some cases, TKIs increase the susceptibility of MDR cancer cells to chemotherapy. As the overexpression of membrane transporter P‐glycoprotein (P‐gp) is the most com-mon alteration in MDR cancer cells, we investigated the effects of TKI pyrazolo[3,4‐d]pyrimidines on P‐gp inhibition in two cellular models comprising sensitive and corresponding MDR cancer cells (human non‐small cell lung carcinoma and colorectal adenocarcinoma). Tested TKIs showed collateral sensitivity by inducing stronger inhibition of MDR cancer cell line viability. Moreover, TKIs directly interacted with P‐gp and inhibited its ATPase activity. Their potential P‐gp binding site was proposed by molecular docking simulations. TKIs reversed resistance to doxorubicin and paclitaxel in a concentration‐dependent manner. The expression studies excluded the indirect effect of TKIs on P‐gp through regulation of its expression. A kinetics study showed that TKIs decreased P‐gp activity and this effect was sustained for seven days in both MDR models. Therefore, pyrazolo[3,4‐d]pyrimidines with potential for reversing P‐gp‐mediated MDR even in prolonged treatments can be considered a new therapeutic strategy for overcoming cancer MDR. |
URI: | http://hdl.handle.net/2067/45991 | ISSN: | 2072-6694 | DOI: | 10.3390/cancers13215308 | Diritti: | CC0 1.0 Universal |
È visualizzato nelle collezioni: | A1. Articolo in rivista |
File in questo documento:
File | Descrizione | Dimensioni | Formato | Existing users please |
---|---|---|---|---|
cancers-13-05308-v2.pdf | Article | 4.21 MB | Adobe PDF | Richiedi una copia |
SCOPUSTM
Citations
20
7
Last Week
0
0
Last month
3
3
controllato il 24-mar-2024
Page view(s)
51
Last Week
0
0
Last month
0
0
controllato il 27-mar-2024
Download(s)
3
controllato il 27-mar-2024
Google ScholarTM
Check
Altmetric
Questo documento è distribuito in accordo con Licenza Creative Commons